Novartis(NVS) - 2021 Q4 - Annual Report

Novartis Fourth Quarter and Full Year 2021 Condensed Financial Report – Supplementary Data | INDEX | Page | | --- | --- | | GROUP AND DIVISIONAL OPERATING PERFORMANCE | | | Group | 3 | | Innovative Medicines | 7 | | Sandoz | 14 | | CASH FLOW AND GROUP BALANCE SHEET | 16 | | INNOVATION REVIEW | 19 | | CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | | | Consolidated income statements | 22 | | Consolidated statements of comprehensive income | 24 | | Consolidated balance sheets | 25 | | Consolidated statements of ...